BJMO - volume 18, issue 6, october 2024
I. Kindts MD, PhD, A. Baten MD, B. Bussels MD, A. De Caluwé MD, L. Donnay MD, L. Goethals MD, PhD, M. Machiels MD, PhD, V. Remouchamps MD, PhD, L. Veldeman MD, PhD, C. Weltens MD, PhD, P. Poortmans MD, PhD
Primary treatment of preference for a local or locoregional breast cancer is breast-conserving therapy (this is breast-conserving surgery followed by radiation therapy). When a breast cancer recurs, or in case of a second ipsilateral breast cancer, the optimal treatment strategy is less well defined than in the primary setting. Standard of care is salvage mastectomy. However, avoidance of mastectomy, if oncologically safe, has proven to be associated with improved patient satisfaction in terms of cosmetic outcome and quality of life apart from cost and resource implications for healthcare providers. With this manuscript, the Belgian Breast Group of the BeSTRO sets up some basic principles regarding repeat breast-conserving therapy awaiting international guidelines.
(BELG J MED ONCOL 2024;18(6):235-238)
Read moreBJMO - volume 14, issue 3, may 2020
J. De Grève MD, PhD, M. Peeters MD, PhD, V. Remouchamps MD, PhD, Y. Lievens MD, PhD, M. Lambrecht MD, PhD
These guidelines are a summary derived from national and international guidelines.1–7
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
